Details of the Drug Formulaction

General Information of Drug Formulation (ID: F24306)

• Formulation Name: Lixisenatide 100 mcg/ml Injection
• Company: Sanofi-Aventis U.S.

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Lixisenatide	(DM0QJDC)	Type-2 diabetes	5A11	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Glycerin	(E00026)	753	Antimicrobial preservative; Emollient; Flavoring agent; Humectant; Lubricant; Plasticizing agent; Solvent; Suppository base; Tonicity agent; Viscosity-controlling agent
Hydrochloric acid	(E00015)	313	Acidulant
Metacresol	(E00016)	342	Antimicrobial preservative
Methionine	(E00030)	876	Buffering agent; Flavoring agent
Sodium acetate	(E00431)	517045	Antimicrobial preservative; Buffering agent; Flavoring agent
Sodium hydroxide	(E00234)	14798	Alkalizing agent
Water	(E00035)	962	Solvent